Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kovar

Showing results (111-120 of 1,127) with videos related to

Pageof 113
Sort By:
Pharmazie in Unserer Zeit|September 1, 1990
[Synthetic drugs of abuse of the second generation (so-called designer drugs). 2. Analysis of arylalkylamines (amphetamine)]C Rösch, K A Kovar
Lancet (London, England)|July 27, 1996
HIV and the paediatrician as the child's advocateC Duke, I Z Kovar
Journal of Separation Science|September 1, 2004
Definite peak identification of (R)-and (S)-methadone and (R)- and (S)-EDDP using established HPLC and CE methodsSandra Trkulja, Karl-Artur Kovar
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|April 20, 2002
Optimize APC revenue with process-oriented assessmentsMichael S Kovar, Elizabeth Lowery
Analytical and Bioanalytical Chemistry|September 2, 2005
Acid-base characterization of 5-hydroxypyrazine-2-carboxylic acid and the role of ionic equilibria in the optimization of some process conditions for its biocatalytic productionM Sak-Bosnar, K Kovar
Planta Medica|June 1, 1992
Adhyperforin: A Homologue of Hyperforin from Hypericum perforatumP Maisenbacher, K A Kovar
Archiv Der Pharmazie|May 1, 1978
[Color reaction of benzylpenicillin with fuming nitric acid]K A Kovar, R Weber
Archiv Der Pharmazie|October 1, 1980
[Determination of creatinine in serum. 2. Elimination of creatine interference with the Jaffe enzyme color test]K A Kovar, G Löhberg
Journal of Chromatography|October 1, 1982
Analysis of essential oil mixtures in ointmentsK A Kovar, A Sakmann
Archiv Der Pharmazie|July 1, 1974
[Colour reaction of drugs possessing substituted aniline structure. 1. Coloration by Vitali-Morin (author's transl)]K A Kovar, U Bitter
Pageof 113

Showing results (111-120 of 1,127) with videos related to

Sort By:
Pageof 113
Pharmazie in Unserer Zeit|September 1, 1990
[Synthetic drugs of abuse of the second generation (so-called designer drugs). 2. Analysis of arylalkylamines (amphetamine)]C Rösch, K A Kovar
Lancet (London, England)|July 27, 1996
HIV and the paediatrician as the child's advocateC Duke, I Z Kovar
Journal of Separation Science|September 1, 2004
Definite peak identification of (R)-and (S)-methadone and (R)- and (S)-EDDP using established HPLC and CE methodsSandra Trkulja, Karl-Artur Kovar
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|April 20, 2002
Optimize APC revenue with process-oriented assessmentsMichael S Kovar, Elizabeth Lowery
Analytical and Bioanalytical Chemistry|September 2, 2005
Acid-base characterization of 5-hydroxypyrazine-2-carboxylic acid and the role of ionic equilibria in the optimization of some process conditions for its biocatalytic productionM Sak-Bosnar, K Kovar
Planta Medica|June 1, 1992
Adhyperforin: A Homologue of Hyperforin from Hypericum perforatumP Maisenbacher, K A Kovar
Archiv Der Pharmazie|May 1, 1978
[Color reaction of benzylpenicillin with fuming nitric acid]K A Kovar, R Weber
Archiv Der Pharmazie|October 1, 1980
[Determination of creatinine in serum. 2. Elimination of creatine interference with the Jaffe enzyme color test]K A Kovar, G Löhberg
Journal of Chromatography|October 1, 1982
Analysis of essential oil mixtures in ointmentsK A Kovar, A Sakmann
Archiv Der Pharmazie|July 1, 1974
[Colour reaction of drugs possessing substituted aniline structure. 1. Coloration by Vitali-Morin (author's transl)]K A Kovar, U Bitter
Pageof 113